[PDF][PDF] Heterogenous populations of tissue-resident CD8+ T cells are generated in response to infection and malignancy

JJ Milner, C Toma, Z He, NS Kurd, QP Nguyen… - Immunity, 2020 - cell.com
JJ Milner, C Toma, Z He, NS Kurd, QP Nguyen, B McDonald, L Quezada, CE Widjaja…
Immunity, 2020cell.com
Tissue-resident memory CD8+ T cells (Trm) provide host protection through continuous
surveillance of non-lymphoid tissues. Using single-cell RNA-sequencing (scRNA-seq) and
genetic reporter mice, we identified discrete lineages of intestinal antigen-specific CD8+ T
cells, including a Blimp1 hi Id3 lo tissue-resident effector cell population most prominent in
the early phase of acute viral and bacterial infections and a molecularly distinct Blimp1 lo Id3
hi tissue-resident memory population that subsequently accumulated at later infection time …
Summary
Tissue-resident memory CD8+ T cells (Trm) provide host protection through continuous surveillance of non-lymphoid tissues. Using single-cell RNA-sequencing (scRNA-seq) and genetic reporter mice, we identified discrete lineages of intestinal antigen-specific CD8+ T cells, including a Blimp1hiId3lo tissue-resident effector cell population most prominent in the early phase of acute viral and bacterial infections and a molecularly distinct Blimp1loId3hi tissue-resident memory population that subsequently accumulated at later infection time points. These Trm populations exhibited distinct cytokine production, secondary memory potential, and transcriptional programs including differential roles for transcriptional regulators Blimp1, T-bet, Id2, and Id3 in supporting and maintaining intestinal Trm. Extending our analysis to malignant tissue, we also identified discrete populations of effector-like and memory-like CD8+ T cell populations with tissue-resident gene-expression signatures that shared features of terminally exhausted and progenitor-exhausted T cells, respectively. Our findings provide insight into the development and functional heterogeneity of Trm cells, which has implications for enhancing vaccination and immunotherapy approaches.
cell.com